Saturday, February 04, 2012
 
 
  Home arrow Abortion arrow Power Point: Abortion / RU486 /Maternal Mortality arrow RU 486, or Mifeprex, Abortion & Maternal Mortality
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

Because of Good Scientific Research, She Changed her Mind

In a workshop in 2003, the National Cancer Institute denied an abortion-breast cancer link.

Dr. Louise Brinton, an NCI official who helped organize the 2003 conference, has now reversed her opinion, admitting that abortion and oral contraceptives do raise breast cancer risk.

40% increased risk for breast cancer for women who have abortions

Dr. Brinton's changed opinion is due to the results of a study she co-authored with researcher Jessica Dolle in 2009, which documents a 40% increased risk for breast cancer for women who have abortions, and up to a 320% risk increase for breast cancer for women using oral contraceptives.

[February 2010, Cincinnati RT Life News Brief]

 
RU 486, or Mifeprex, Abortion & Maternal Mortality PDF Print E-mail

"Elective Medical Abortion and Maternal Mortality" is a summary of research on the relationship between medical or chemical abortion (RU 486, or Mifeprex) and maternal mortality (death of the pregnant woman).

Click here to view this presentation.

 

 
< Prev


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2012 All Rights Reserved